HB3454 - 104th General Assembly (2025-2026)

EPINEPHRINE DELIVERY DEVICE
Last Action
2/13/2026 - House: Placed on Calendar 2nd Reading - Short Debate
Statutes Amended In Order of Appearance
20 ILCS 2610/40  
50 ILCS 705/10.19  
105 ILCS 5/22-30  
215 ILCS 5/356z.33  
225 ILCS 60/65  
410 ILCS 27/1  
410 ILCS 27/5  
410 ILCS 27/10  
410 ILCS 27/15  
410 ILCS 27/20  
410 ILCS 607/10  
410 ILCS 620/3.21  from Ch. 56 1/2, par. 503.21
410 ILCS 642/20  
Synopsis As Introduced
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
Actions
DateChamberAction
2/07/2025HouseFiled with the Clerk by Rep. Joyce Mason
2/18/2025HouseFirst Reading
2/18/2025HouseReferred to Rules Committee
3/11/2025HouseAssigned to Prescription Drug Affordability & Accessibility Committee
3/19/2025HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
3/20/2025HousePlaced on Calendar 2nd Reading - Short Debate
3/26/2025HouseAdded Co-Sponsor Rep. Jawaharial Williams
3/26/2025HouseAdded Co-Sponsor Rep. Harry Benton
3/26/2025HouseAdded Co-Sponsor Rep. Dagmara Avelar
3/26/2025HouseSecond Reading - Short Debate
3/26/2025HouseHeld on Calendar Order of Second Reading - Short Debate
4/08/2025HouseAdded Co-Sponsor Rep. Camille Y. Lilly
4/11/2025HouseRule 19(a) / Re-referred to Rules Committee
1/21/2026HouseAdded Chief Co-Sponsor Rep. Martha Deuter
2/11/2026HouseApproved for Consideration Rules Committee; 005-000-000
2/13/2026HousePlaced on Calendar 2nd Reading - Short Debate